Physician profile
Candida Catucci
NPI 1528172079
$726.46
in general payments reported to CMS, 2019-2025
10 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $46.43 · 2021: $132 · 2022: $18.67 · 2023: $89.22 · 2024: $74.41 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $150.95 | 2022-2025 | Ozempic, Rybelsus |
| Horizon Therapeutics Plc | $131.87 | 2021 | |
| Amarin Pharma, INC. | $120.78 | 2019 | |
| Astellas Pharma US INC | $82.73 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $68.84 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $67.97 | 2019-2024 | Breztri |
| Lilly USA, LLC | $49.01 | 2019-2020 | |
| Shire North American Group INC | $23.73 | 2019 | |
| Merck Sharp & Dohme LLC | $15.51 | 2019 | |
| Allergan, INC. | $15.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candida Catucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.